Podcast: Is Remdesivir Approvable? DARPA's Race To Find An Antibody ‘Firebreak’ Plus Pharma's Pandemic Q1s

Analysis On Pharma In The Time Of COVID-19

 
• By Andrew McConaghie, Kevin Grogan, and Sarah Karlin-Smith

A review of developments including Gilead's imminent 'big reveal' of remdesivir data and how big pharma has fared financially in the first three months of 2020.

Cinema_Billboard_Covid19
The world is looking for an exit from lockdown: could antibody drugs help and be available before the end of 2020?

More from Clinical Trials

More from R&D